ECSP088300A - Derivados de benzotiadiazolilfenilalquilamina para uso en el tratamiento de condiciones mejoradas por la retoma de monoamina - Google Patents
Derivados de benzotiadiazolilfenilalquilamina para uso en el tratamiento de condiciones mejoradas por la retoma de monoaminaInfo
- Publication number
- ECSP088300A ECSP088300A EC2008008300A ECSP088300A ECSP088300A EC SP088300 A ECSP088300 A EC SP088300A EC 2008008300 A EC2008008300 A EC 2008008300A EC SP088300 A ECSP088300 A EC SP088300A EC SP088300 A ECSP088300 A EC SP088300A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- treatment
- conditions
- combinations
- retoma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
La presente invención se dirige a derivados benzotiadiazolilfenilalquilamina de la Fórmula I: o una sal farmacéuticamente aceptable de este, composiciones que contienen estos derivados, y los métodos de uso para la prevención y el tratamiento de condiciones de condiciones mejoradas por la retoma de monoamina que incluye, inter alia, síntomas vasomotores (VMS), disfunción sexual, trastornos gastrointestinales y genitourinarios, síndrome de fatiga crónica, síndrome de fibromialgia, trastornos del sistema nervioso central, y combinaciones de estos, particularmente aquellas condiciones seleccionadas del grupo que consiste de trastorno depresivo mayor, síntomas vasomotores, estrés e incontinencia urinaria alta, fibromialgia, dolor, neuropatía diabética, y combinaciones de este.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72169305P | 2005-09-29 | 2005-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088300A true ECSP088300A (es) | 2008-04-28 |
Family
ID=37684875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008300A ECSP088300A (es) | 2005-09-29 | 2008-03-20 | Derivados de benzotiadiazolilfenilalquilamina para uso en el tratamiento de condiciones mejoradas por la retoma de monoamina |
Country Status (19)
Country | Link |
---|---|
US (1) | US7601744B2 (es) |
EP (1) | EP1934193A1 (es) |
JP (1) | JP2009510095A (es) |
KR (1) | KR20080050453A (es) |
CN (1) | CN101277941A (es) |
AR (1) | AR055660A1 (es) |
AU (1) | AU2006297208A1 (es) |
BR (1) | BRPI0616462A2 (es) |
CA (1) | CA2624096A1 (es) |
CR (1) | CR9829A (es) |
EC (1) | ECSP088300A (es) |
GT (1) | GT200600441A (es) |
IL (1) | IL190273A0 (es) |
NO (1) | NO20081235L (es) |
PE (1) | PE20070544A1 (es) |
RU (1) | RU2008110082A (es) |
TW (1) | TW200804325A (es) |
WO (1) | WO2007041258A1 (es) |
ZA (1) | ZA200802774B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2007003590A1 (es) * | 2006-12-12 | 2008-02-29 | Wyeth Corp | Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt |
US20090156826A1 (en) * | 2007-12-12 | 2009-06-18 | Wyeth | Methods for the preparation of hydroxy-substituted aryl sulfamide compounds |
NZ594937A (en) * | 2008-02-19 | 2013-03-28 | Adolor Corp | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
US20090233959A1 (en) | 2008-02-19 | 2009-09-17 | Adolor Corporation | Beloxepin and analogs for the treatment of pain |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200002507T2 (tr) | 1998-03-02 | 2000-12-21 | Eli Lilly And Company | Ateş basmasını azaltmak için fluoksetin hidroklorür |
US7410996B2 (en) | 2002-11-05 | 2008-08-12 | Eli Lilly And Company | 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
US7491723B2 (en) | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
-
2006
- 2006-09-27 JP JP2008533628A patent/JP2009510095A/ja not_active Withdrawn
- 2006-09-27 BR BRPI0616462-5A patent/BRPI0616462A2/pt not_active IP Right Cessation
- 2006-09-27 TW TW095135772A patent/TW200804325A/zh unknown
- 2006-09-27 WO PCT/US2006/037962 patent/WO2007041258A1/en active Application Filing
- 2006-09-27 EP EP06815744A patent/EP1934193A1/en not_active Withdrawn
- 2006-09-27 PE PE2006001171A patent/PE20070544A1/es not_active Application Discontinuation
- 2006-09-27 CA CA002624096A patent/CA2624096A1/en not_active Abandoned
- 2006-09-27 KR KR1020087007611A patent/KR20080050453A/ko not_active Application Discontinuation
- 2006-09-27 RU RU2008110082/04A patent/RU2008110082A/ru not_active Application Discontinuation
- 2006-09-27 GT GT200600441A patent/GT200600441A/es unknown
- 2006-09-27 AR ARP060104235A patent/AR055660A1/es unknown
- 2006-09-27 CN CNA2006800360246A patent/CN101277941A/zh active Pending
- 2006-09-27 US US11/528,792 patent/US7601744B2/en not_active Expired - Fee Related
- 2006-09-27 AU AU2006297208A patent/AU2006297208A1/en not_active Abandoned
-
2008
- 2008-03-10 NO NO20081235A patent/NO20081235L/no unknown
- 2008-03-18 IL IL190273A patent/IL190273A0/en unknown
- 2008-03-20 EC EC2008008300A patent/ECSP088300A/es unknown
- 2008-03-26 CR CR9829A patent/CR9829A/es not_active Application Discontinuation
- 2008-03-28 ZA ZA200802774A patent/ZA200802774B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GT200600441A (es) | 2007-09-19 |
IL190273A0 (en) | 2009-09-22 |
BRPI0616462A2 (pt) | 2011-06-21 |
TW200804325A (en) | 2008-01-16 |
AU2006297208A1 (en) | 2007-04-12 |
CA2624096A1 (en) | 2007-04-12 |
AR055660A1 (es) | 2007-08-29 |
US20070072918A1 (en) | 2007-03-29 |
WO2007041258A1 (en) | 2007-04-12 |
NO20081235L (no) | 2008-06-20 |
EP1934193A1 (en) | 2008-06-25 |
CR9829A (es) | 2008-04-28 |
PE20070544A1 (es) | 2007-07-26 |
US7601744B2 (en) | 2009-10-13 |
CN101277941A (zh) | 2008-10-01 |
ZA200802774B (en) | 2009-01-28 |
KR20080050453A (ko) | 2008-06-05 |
JP2009510095A (ja) | 2009-03-12 |
RU2008110082A (ru) | 2009-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066899A (es) | Derivados fenilaminopropanol y métodos de uso | |
MA31084B1 (fr) | Derives de piperidine agonistes de gpcr | |
CR10866A (es) | Derivados de aril sulfamida y metodos para su uso | |
CO2020006224A2 (es) | Nuevos profármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson | |
PE20090154A1 (es) | Metodos para tratar y monitorear el tratamiento de transtornos asociados con il-13 | |
EA201200406A1 (ru) | Соединения и композиции, которые являются модуляторами активности tlr | |
EA201991316A1 (ru) | Конъюгаты, содержащие двойной агонист glp-1/глюкагона, линкер и гиалуроновую кислоту | |
BRPI0606690A2 (pt) | composto; uso do composto para o tratamento de uma doença ou distúrbio associado com uma atividade excessiva de bace; e composição farmacêutica | |
EA200870127A1 (ru) | Полициклические производные аминокислот и способы их применения | |
BRPI0509513A (pt) | derivados de fenilaminopropanol heterocìclicos como moduladores da captação de monoamina para o tratamento de sintomas vasomotores (vms) | |
EA201001595A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
AR061289A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
AR068510A1 (es) | Derivados de 4-fenil-1h-piridin-2-ona - 1,3 disustituidos, composiciones farmaceuticas que los contienen y usos de los mismos para tratar o prevenir trastornos del sistema nervioso central. | |
ECSP088300A (es) | Derivados de benzotiadiazolilfenilalquilamina para uso en el tratamiento de condiciones mejoradas por la retoma de monoamina | |
UY30414A1 (es) | Metano sulfonatos, propano-1-sulfonatos y ciclopropan sulfonatos sustituidos con [2,3,4,8-tetrahidroimidazo-[1,5-al-pirimidin-8-il]-fenilo, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
AR056080A1 (es) | 7-[2-[4-(6-fluoro-3-metil-1,2-benciosoxazol-5-il)-1-piperazinil]etil]-2-(1-propinil)-7h-pirazol-[4,3-e]-[1,2,4]-triazol-[1,5-c] -pirimidin-5-amine | |
EA201170795A1 (ru) | Антагонисты ccr2 группы 4-азетидинил-1-гетероарил-циклогексанола | |
DOP2021000045A (es) | Dioxociclobutenilamino-3-hidroxi-picolinamidas n-sustituidas útiles como inihibidores de ccr6 | |
BR112015023761A2 (pt) | moduladores de molécula pequena de pcsk9 e seus métodos e usos | |
EA200801120A1 (ru) | Нафтильные производные в качестве ингибиторов агрегирования бета-амилоида | |
CR8313A (es) | Derivados de arilo cicloalcanol sustituidos y metodos de uso de los mismos | |
BRPI0415410A (pt) | derivados de arilalquil-e cicloalquilalquil-piperazina e métodos de seu uso | |
WO2005037207A3 (en) | Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) | |
WO2007041257A3 (en) | Substituted propylamine derivatives and methods of their use | |
BRPI0415478A (pt) | derivados de fenilpiperazina cicloalcanol e métodos de seu uso |